NORMA SOMOHANO-MENDIOLA: Open Payments
NPI 1942608963 · MCALLEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$144 in 5 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $187 · 2025 $144
Food & beverage: $144
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 1 | $108 |
| Evofem Biosciences, Inc. | 3 | $34 |
| Organon LLC | 1 | $2 |
Products named: DAXXIFY, Phexxi, NEXPLANON.
Industry payments across TX — which companies pay providers there.
